ga

Skip to content

My Files [0]

These are the files you have added to your collection.

  • You don't have any documents yet, feel free to browse the website and add documents.

News for 2002

The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.

For details on how to contact CADTH, visit our Contact Us page.

Endovascular Grafts Not Appropriate for all Abdominal Aortic Aneurysm Patients

December 19, 2002

OTTAWA - The use of endovascular grafts (EVG) for the elective repair of abdominal aortic aneurysms (AAA) is not appropriate for all patients, a technology report released today by the Canadian ...

Barb Shea Appointed Director of Common Drug Review Directorate

December 12, 2002

OTTAWA - Dr. Jill M. Sanders, President of the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), is pleased to announce the appointment of Barb Shea as Director, Common Drug ...

Verteporfin photodynamic therapy moderately slows progression of wet AMD

December 12, 2002

OTTAWA - Verteporfin photodynamic therapy treatment for two years for patients with wet age-related macular degeneration (AMD) modestly reduces the incidence of legal central blindness, a ...

CCOHTA to Establish a Roster of Pharmaceutical Researchers

November 26, 2002

OTTAWA - The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) has issued a request for expressions of interest from qualified individuals interested in conducting clinical ...

New Class of Drugs Effective in Treating Diabetes?

November 13, 2002

OTTAWA - Two drugs that are members of the newest class of oral anti-diabetic agents, the thiazolidinediones, have an innovative mechanism of action but their effect on blood sugar reduction in ...

Film Screen Mammography Should Remain the Standard for Detecting Breast Cancer, CCOHTA Report Concludes

November 11, 2002

OTTAWA - Conventional film screen mammography, the current standard for detecting breast cancer, is preferable to digital mammography at this time, a technology assessment released today by the ...

CCOHTA To Hold Information Session On Common Drug Review

October 23, 2002

OTTAWA - The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) will hold an information session for Canadian pharmaceutical companies to outline the new submission ...

Taxane Regimens: Better Response Rate, Similar Survival Rate

October 08, 2002

Chemotherapy regimens containing a taxane (paclitaxel and docetaxel) do a better job overall than non-taxane regimens in terms of reducing tumor size but they don't significantly improve the ...

No Evidence That Long-acting Beta-Agonists Outperform Current First Line Treatment for Non-reversible COPD

September 17, 2002

Using a long-acting beta-agonist rather than ipratropium bromide as the first line treatment for stable non-reversible chronic obstructive pulmonary disease (COPD) would increase costs without ...

Fondaparinux for Post-operative Venous Thrombosis Prophylaxis

August 19, 2002

The Canadian Coordinating Office for Health Technology Assessment has published an emerging technology bulletin on Fondaparinux (ArixtraTM), a synthetic anticoagulant that was recently approved ...

Uterine Artery Embolization for the Treatment of Fibroids

August 19, 2002

The Canadian Coordinating Office for Health Technology Assessment has published an emerging technology bulletin on Uterine Artery Embolization for the Treatment of Fibroids. UAE is a non-surgical ...

Technology Report: Pediatric Economic Dababase Evaluation (PEDE) Project

August 16, 2002

The Canadian Coordinating Office for Health Technology Assessment has published The Pediatric Economic Database Evaluation (PEDE) Project, the first attempt to catalogue, analyze and appraise ...

Medical High Tech Inventory Increased 45% Since 1997

April 11, 2002

OTTAWA - Almost half of the high tech equipment used in publicly funded sites across Canada was installed between 1997 and 2001, according to a report released today by the Canadian Coordinating ...

Follow Us

Share